Lord, Abbett & Co
ICPT

Lord, Abbett & Co’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Lord, Abbett & Co’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,835
Closed -$7.6M – 966
2015
Q3 		$7.6M Buy
45,835
+6,164
+16% +$1.36M 0.02% 643
2015
Q2 		$9.58M Sell
39,671
-32,757
-45% -$8.72M 0.03% 648
2015
Q1 		$20.4M Buy
+72,428
New +$15.7M 0.05% 482
2014
Q4 		– Sell
-180,491
Closed -$42.7M – 1002
2014
Q3 		$42.7M Sell
180,491
-24,144
-12% -$6.16M 0.11% 268
2014
Q2 		$48.4M Buy
+204,635
New +$53.9M 0.11% 260
2014
Q1 		– Sell
-70,334
Closed -$4.8M – 1089
2013
Q4 		$4.8M Sell
70,334
-80,167
-53% -$4.63M 0.01% 851
2013
Q3 		$10.4M Sell
150,501
-1,412
-0.9% -$69.7K 0.02% 634
2013
Q2 		$6.81M Buy
+151,913
New +$5.19M 0.02% 723

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co's ICPT Position: Q4 2015 in Review

Lord, Abbett & Co sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 45,835 shares — an estimated $7.6M sold.

Lord, Abbett & Co first reported a position in ICPT in Q2 2013 and held it in 8 quarters. The position peaked at $48.4M in Q2 2014. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Lord, Abbett & Co reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 45,835 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $7.6M.
  • Lord, Abbett & Co first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
  • Lord, Abbett & Co's Intercept Pharmaceuticals, Inc. position peaked at $48.4M in Q2 2014.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Lord, Abbett & Co's 13F filing for Q4 2015, filed 16 Feb 2016.